Termination of the CRESCENDO trial
- PMID: 21146095
- DOI: 10.1016/S0140-6736(10)62254-4
Termination of the CRESCENDO trial
Comment on
-
Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial.Lancet. 2010 Aug 14;376(9740):517-23. doi: 10.1016/S0140-6736(10)60935-X. Lancet. 2010. PMID: 20709233 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources